82017-30-9

Basic information

• Product Name: DL-Cyclohexylalanine
• Synonyms: DL-Cyclohexylalanine;H-DL-Cha-OH;-2-(Cyclohexylamino)
• CAS NO: 82017-30-9
• Molecular Formula: C₉H₁₇NO₂
• Molecular Weight: 171.23678
• Product Categories: Peptide
• Mol File: 82017-30-9.mol
• Article Data: 19

Chemical Properties

• Appearance: /
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• CAS DataBase Reference: DL-Cyclohexylalanine(CAS DataBase Reference)
• NIST Chemistry Reference: DL-Cyclohexylalanine(82017-30-9)
• EPA Substance Registry System: DL-Cyclohexylalanine(82017-30-9)

Safety Data

• Hazardous Substances Data: 82017-30-9(Hazardous Substances Data)

Usage

General Description

DL-Cyclohexylalanine is a chemical compound that is classified as an amino acid derivative. It is composed of a cyclohexane ring attached to an alanine amino acid. DL-Cyclohexylalanine is often used in the pharmaceutical industry as a building block for the synthesis of various bioactive molecules, especially in the development of new drugs and applications in medicinal chemistry. DL-Cyclohexylalanine has also been studied for its potential role in the treatment of neurological disorders and neurodegenerative diseases, due to its ability to modulate neuronal activity and function. Overall, DL-Cyclohexylalanine is a versatile and important chemical compound with potential therapeutic applications.

Upstream product

• 108-91-8 cyclohexylamine 
• 598-72-1 2-Bromopropionic acid 
• 127-17-3 2-oxo-propionic acid 
• 1195-49-9 N-cyclohexylpropionaldimine 
• 90608-71-2 2-cyclohexylimino-propionic acid 
• 67105-33-3 ethyl 2-(cyclohexylamino)propanoate 
• 62134-88-7 N-(2,2-dimethylpropylidene)cyclohexanamine 
• 156801-27-3 1-(2-adamantan-1-yl-2-oxoethyl)-L-proline 
• 6963-43-5 c-hexyl pyruvate 

Downstream Products

• 5459-93-8 N-ethyl-cyclohexanamine 

Relevant articles and documents

FUNCTIONALIZED FLUORINE CONTAINING PHTHALOCYANINE MOLECULES

Functionalized fluorine containing phthalocyanine molecules, methods of making, and methods of use in diagnostic applications and disease treatment are disclosed herein. In some embodiments, the fluorine containing phthalocyanine molecules are functionalized with a reactive functional group or at least one cancer-targeting ligand (CTL). The CTL can facilitate more efficient binding and/or internalization to a cancer cell than to a healthy cell. The CTL can inhibit expression of oncoprotein in some embodiments. The pthalocyanine moiety can be used in diagnostic applications, such as fluorescence labeling of a cancer cell, and/or treatment applications, such as catalyzing formation of a reactive oxygen species (ROS) which can contribute to cell death of a cancer cell.

D-amino acid dehydrogenase and method of making D-amino acids

Polypeptides capable of catalyzing the reductive amination of a 2-ketoacid to its corresponding D-amino acid are provided. The polypeptides can be prepared by mutagenesis of, e.g., a diaminopimelate dehydrogenase. Also provided is a method of making a D-amino acid using a catalytically active polypeptide, wherein a 2-ketoacid is allowed to contact the polypeptide in the presence of a nicotinamide cofactor and ammonia or an ammonia source.

METHOD OF SEARCHING SUBSTANE HAVING ANTIDIABETIC ACTIVITY

The present invention provides a screening method of a substance which inhibits binding of a condensed purine derivative to a pancreatic β cell or a treated product of the cell, a substance which inhibits binding of a condensed purine derivative to a protein capable of the condensed purine derivative, and a substance which inhibits the expression or enzymatic activity of a protein capable of a condensed purine derivative, which comprises using the condensed purine derivative and a pancreatic β cell or a treated product of the cell or a protein capable of binding to the condensed purine derivative.